Trials / Conditions / Glioblastoma WHO Grade IV
Glioblastoma WHO Grade IV
6 registered clinical trials studyying Glioblastoma WHO Grade IV — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Phase 0 With Expansion Phase Clinical Trial of Quisinostat Plus Radiotherapy in Newly-diagnosed and Recurrent NCT06824662 | Nader Sanai | EARLY_Phase 1 |
| Recruiting | Clinical Trial of BMS-986504 in Recurrent GBM Patients NCT06883747 | Nader Sanai | EARLY_Phase 1 |
| Recruiting | BC008-1A Injection for Recurrent CNS WHO G4 Glioma NCT06773481 | Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd. | Phase 1 |
| Not Yet Recruiting | CSF Proteomic Characterization of Glioblastomas NCT06845020 | Univeridad Autonoma de Guadalajara | — |
| Unknown | International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013) NCT03243461 | University of Göttingen | Phase 3 |
| Active Not Recruiting | Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in P NCT03405792 | University of Florida | Phase 2 |